In Every Issue
- Enabling Technologies
FIRST BASE - Next-generation sequencing and adaptive trials are both gaining ground, and promise to profoundly impact medicine.
By Kevin Davies
- Entelos' First Year as a Public Company
THE RUSSELL TRANSCRIPT - After going public last year, Entelos released its first financial report as a public company, and reports both gains and losses.
By John Russell
- New Products